ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

International Research Data Bank Up And Operating Through NLM Systems

September 20, 1974

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NCI RFA: Basic Biobehavioral Research

August 6, 1999

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994